Labelling of human Wharton's jelly-derived mesenchymal stem cells with gold nanorods by biomimicry method.
Farshid Qiyami-HourRonak ShabaniBehnaz AshtariAlaa MoinzadehMehdi MehdizadehPublished in: Cell biochemistry and function (2021)
Mesenchymal stem cell (MSC)-based cell therapy can provide opportunities for the treatment of various diseases. However, when used in vivo, these cells should be labelled and monitored by a non-invasive method during delivery to the desired locations within the body. This study describes a biomimicry method that effectively labels human Wharton's jelly-derived MSCs (hWJ-MSCs) with a photoacoustics (PA) contrast agent, gold nanorods (GNRs), without the need for transfection agents (TAs). In this method for cell labelling, the hWJ-MSCs were co-incubated with non-adherent cells isolated from fresh umbilical cord for 2 days immediately before incubation with GNRs. Next, hWJ-MSCs were labelled with the GNRs at a concentration of approximately 1010 nanorads/mL (NR/mL) followed by transmission electron microscopy (TEM) and inductively coupled plasma mass spectroscopy (ICP-MS) to verify their labelling effectiveness. The GNRs-labelled MSCs prepared by this method had an intracellular gold (Au) concentration of 3.4 ± 0.4 pg/cell, which is an acceptable amount for cell labelling.
Keyphrases
- umbilical cord
- mesenchymal stem cells
- cell therapy
- induced apoptosis
- bone marrow
- endothelial cells
- single cell
- stem cells
- cell cycle arrest
- randomized controlled trial
- systematic review
- mass spectrometry
- multiple sclerosis
- quantum dots
- endoplasmic reticulum stress
- electron microscopy
- ms ms
- high resolution
- pluripotent stem cells
- induced pluripotent stem cells
- magnetic resonance imaging